'Mg bid' diaporamas de présentation

1.19k views • 80 slides

Herbal / Drug Interactions

Herbal / Drug Interactions. Gary W. Elmer, R.Ph.,Ph.D. Department of Medicinal Chemistry, elmer@u.washington.edu 11/03/06. Elmer et al. unpublished. Steps for Detecting and Advising on Herbal/Drug Interactions. Is the patient taking any herbal supplements?

982 views • 73 slides

TREATMENT OF DEPRESSION IN THE ELDERLY

1.97k views • 46 slides

GUIDELINES FOR HIV POST-EXPOSURE PROPHYLAXIS FOLLOWING SEXUAL ASSAULT

GUIDELINES FOR HIV POST-EXPOSURE PROPHYLAXIS FOLLOWING SEXUAL ASSAULT. Developed by the New York State Department of Health, AIDS Institute and Rape Crisis. Rationale for Sexual Assault PEP Guidelines.

635 views • 42 slides

Ob Gyn and Male GU

729 views • 36 slides

Evaluation of Ranolazine in Patients with Type 2 Diabetes Mellitus and Chronic Stable Angina Results from the TERISA Ran

Evaluation of Ranolazine in Patients with Type 2 Diabetes Mellitus and Chronic Stable Angina Results from the TERISA Randomized Clinical Trial.

643 views • 36 slides

ER Direct Case: Management of Atrial Fibrillation and Post-Treatment Bleeding in Patient with Prior TIA

ACS and Thrombosis in the Emergency Setting. ER Direct Case: Management of Atrial Fibrillation and Post-Treatment Bleeding in Patient with Prior TIA. AF, Stroke and New Oral Anticoagulants. Atrial fibrillation (AF) affects over 350 000 Canadians.

551 views • 35 slides

457 views • 31 slides

FDA Experience with End of Phase IIa Meetings: An Attempt to Improve Drug Development Decisions

FDA Experience with End of Phase IIa Meetings: An Attempt to Improve Drug Development Decisions. Acknowledge: Larry Lesko, Don Stanski, Joga Gobburu, Peter Lee, Yaning Wang, Jenny Zheng and many others. Bob Powell, Pharm.D. Office of Clinical Pharmacology FDA powellr@cder.fda.gov

631 views • 30 slides

Endocrine Day 3

Endocrine Day 3. Part 1. Oral Hypoglycemic Agents. Sulfonylurea Cholpropamide (Diabanese) Glipizide (Glucotrol) Glimepride (Amaryl) Glyburide (Diabeta, Micronase). Oral Hypoglycemic Agents. Biguanides Metformin (Glucophage) Glucovance Sulfonyurea+Biguanide.

399 views • 26 slides

Thank you, Dr. Ballentine!

Thank you, Dr. Ballentine!. All the information presented could be helpful to you as community Geriatric Resource Nurses, as you deal with vulnerable older adults who may be wanting to stay in their homes as long as possible.

349 views • 24 slides

Patient Profile

343 views • 24 slides

Pain

Pain. Morning Report Robin Staib, PharmD December 22, 2011. Equianalgesic Doses (100%). 1:3. 1:5. 4mg IV morphine ______ PO morphine 4mg IV M x 3 = 12mg PO morphine 2mg IV dilaudid ______ PO dilaudid 2mg IV M x5 = 10mg PO dilaudid 50mcg IV fentanyl _______ IV morphine

426 views • 23 slides

Health and the IEP

601 views • 21 slides

Health and the IEP

366 views • 21 slides

Session 6: Clinical Diagnosis and Decision-Making Skills

Session 6: Clinical Diagnosis and Decision-Making Skills. Basics of Clinical Mentoring. Learning Objectives. By the end of this session, participants will be able to: Identify concepts of evidence-based medicine Identify common errors in clinical reasoning that should be avoided.

420 views • 17 slides

Apixaban versus Warfarin in Patients with Atrial Fibrillation

Apixaban versus Warfarin in Patients with Atrial Fibrillation. Study by: Granger et al. NEJM, September 2011,Vol. 365. No. 11 Presented by: Amelia Crawford PA-S2. Background. Vitamin K Antagonists (Warfarin) are routinely used in stroke prevention in patients with A.fib

826 views • 17 slides

2.18k views • 7 slides

Steady State

(N=10). Treatment A:. ATV 400 mg QD. +. LPV/r BID Placebo. (N=10). Treatment B:. LPV/r 400/100 mg BID. +. ATV QD Placebo. (N=10). Treatment C:. ATV QD Placebo. +. LPV/r BID Placebo. Clamp. or. A. CLAMP (180 min) + PK Profile. B. C. CLAMP (180 min) + PK Profile. (n=20).

229 views • 1 slides

Vascular Medicine Update

Vascular Medicine Update. Suman Rathbun MD, MS Professor of Medicine Director, Vascular Medicine OUHSC. New Therapies. New anticoagulants VTE prevention in orthopedic surgery VTE treatment CVA prevention in atrial fibrillation Catheter directed thrombectomy / lysis for DVT.

162 views • 0 slides